Skip to main content

Find Clinical Trials

Home
Conditions
Hemostatic Disorders

Clinical trial condition

Hemostatic Disorders

Explore clinical trials studying Hemostatic Disorders. Study availability and eligibility vary by location and protocol.

3,079 public trials 581 recruiting studies

Refine in advanced search Browse all conditions

Hemostatic Disorders trial results

Completed

A Study of Durvalumab in Combination With Lenalidomide With and Without Dexamethasone in Adults With Newly Diagnosed Multiple Myeloma

NCT02685826

Conditions: Blood Protein Disorders, Cardiovascular Diseases, Hematologic Diseases, +12 more
Locations: University of Alabama Birmingham Birmingham, Alabama, United States

Winship Cancer Institute of Emory University Atlanta, Georgia, United States

Beth Israel Deaconess Medical Center Boston, Massachusetts, United States

Dana Farber Cancer Institute Boston, Massachusetts, United States

View all 54 locations

View Trial Details

Completed

Dexamethasone, Carfilzomib, & Nivolumab With Pelareorep for Relapsed/Refractory Multiple Myeloma

NCT03605719

Conditions: Blood Protein Disorders, Cardiovascular Diseases, Hematologic Diseases, +13 more
Locations: Emory University Hospital/Winship Cancer Institute Atlanta, Georgia, United States

Huntsman Cancer Institute/University of Utah Salt Lake City, Utah, United States

View Trial Details

Completed

Novel Drugs After Allo-HSCT in Patients With Multiple Myeloma

NCT04506320

Conditions: Blood Protein Disorders, Cardiovascular Diseases, Hematologic Diseases, +13 more
Locations: Azienda Ospedaliera di Careggi Florence, Italy

Clinica Ematologica - Policlinico Universitario Udine, Italy

View Trial Details

Completed

Panobinostat and Carfilzomib in Treating Participants With Relapsed or Refractory Multiple Myeloma

NCT01301807

Conditions: Blood Protein Disorders, Cardiovascular Diseases, Hematologic Diseases, +16 more
Locations: M D Anderson Cancer Center Houston, Texas, United States

View Trial Details

Completed

Electrophysiological Biomarkers of Chemotherapy-related Cognitive Impairment and Recovery

NCT02767388

Conditions: Acute Lymphoid Leukemia, Acute Myeloid Leukemia, Blood Protein Disorders, +42 more
Locations: University of Nebraska Medical Center Omaha, Nebraska, United States

View Trial Details

Completed

Cardiopulmonary Exercise Testing to Evaluate Pulmonary AVMs

NCT02436213

Conditions: Cardiovascular Abnormalities, Cardiovascular Diseases, Congenital Abnormalities, +11 more
Locations: Hammersmith Hospital, Du Cane Rd London, United Kingdom

View Trial Details

Completed

Investigation of Coagulation Parameters in Hereditary Haemorrhagic Telangiectasia

NCT00230659

Conditions: Cardiovascular Abnormalities, Cardiovascular Diseases, Congenital Abnormalities, +9 more
Locations: Imperial College Hammersmith Campus London, United Kingdom

View Trial Details

Completed

Study of Histological Samples From Patients With Hereditary Haemorrhagic Telangiectasia

NCT00733655

Conditions: Cardiovascular Abnormalities, Cardiovascular Diseases, Congenital Abnormalities, +9 more
Locations: Imperial College Hammersmith Campus London, United Kingdom

View Trial Details

Completed

Frequency of Common Medical Conditions in People With and Without HHT

NCT02464644

Conditions: Cardiovascular Abnormalities, Cardiovascular Diseases, Congenital Abnormalities, +10 more
Locations: NHLI Cardiovascular Sciences, Imperial College London London, United Kingdom

View Trial Details

Completed

A Safety and Effectiveness Study of Vaccine Therapy in Patients With Indolent Lymphoma

NCT00081809

Conditions: Blood Protein Disorders, Cardiovascular Diseases, Chronic Disease, +27 more
Locations: M.D. Anderson Cancer Center Houston, Texas, United States

View Trial Details